Systematic Financial Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.03M | Buy |
1,671,717
+135,534
| +9% | +$327K | 0.11% | 159 |
|
|
2025
Q1 | $3.39M | Sell |
1,536,183
-113,361
| -7% | -$251K | 0.1% | 163 |
|
|
2024
Q4 | $8.99M | Buy |
1,649,544
+37,383
| +2% | +$204K | 0.23% | 132 |
|
|
2024
Q3 | $13.4M | Buy |
1,612,161
+206,499
| +15% | +$1.72M | 0.34% | 119 |
|
|
2024
Q2 | $10.1M | Sell |
1,405,662
-99,491
| -7% | -$712K | 0.31% | 124 |
|
|
2024
Q1 | $13M | Buy |
1,505,153
+180,832
| +14% | +$1.57M | 0.36% | 114 |
|
|
2023
Q4 | $8.67M | Buy |
1,324,321
+150,234
| +13% | +$984K | 0.26% | 133 |
|
|
2023
Q3 | $11.7M | Buy |
1,174,087
+64,472
| +6% | +$645K | 0.38% | 110 |
|
|
2023
Q2 | $13.8M | Buy |
1,109,615
+322,878
| +41% | +$4.01M | 0.44% | 105 |
|
|
2023
Q1 | $11M | Buy |
786,737
+62,991
| +9% | +$883K | 0.36% | 116 |
|
|
2022
Q4 | $10.4M | Buy |
+723,746
| New | +$10.4M | 0.34% | 120 |
|